Log in or Sign up for Free to view tailored content for your specialty!
Pharmacology News
Omega-3 fatty acid supplementation associated with increased AF risk
Omega-3 fatty acid supplementation, especially at higher doses, was associated with elevated risk for atrial fibrillation, according to a meta-analysis of various large-scale randomized controlled trials published in Circulation.
Many patients with breast cancer use cannabis but do not notify their physician
More than 40% of patients with breast cancer reported using cannabis to manage their treatment symptoms, yet most patients did not discuss cannabis use with a physician, according to survey results published in Cancer.
Log in or Sign up for Free to view tailored content for your specialty!
Many recent approvals, upcoming trials for lipid-lowering therapies
In an update on FDA approvals and late-breaking trials in lipid therapies, a speaker reviewed the current and future landscapes of LDL- and triglyceride-lowering therapies.
Medical management of obesity 'viable' option, but 'not a magic wand'
For patients with obesity, medical management options offer a new opportunity for successful treatment.
GI bleeding more common with rivaroxaban than other direct oral anticoagulants
Rivaroxaban appeared associated with a higher rate of gastrointestinal bleeding than other direct oral anticoagulants, according to study results published in Annals of Internal Medicine.
USPSTF advises against starting aspirin for primary CVD prevention in older adults
The U.S. Preventive Services Task Force no longer recommends aspirin for primary CVD prevention in adults aged 60 years or older, according to a draft recommendation issued today.
Implantable monitor detects arrhythmias in patients on psychotropic medications
An implantable loop recorder feasibly and acceptably monitored arrythmias among patients taking psychotropic medication, according to results of a cohort study in a research letter published in JAMA Psychiatry.
Pharmacotherapy plus measurement-based care improves depression outcomes
Measurement-based care decreased depression severity, promoted remission and improved medication adherence among patients with depressive disorders treated with pharmacotherapy, according to a study.
Gantenerumab receives breakthrough therapy designation as Alzheimer’s treatment
The FDA has granted breakthrough therapy designation to gantenerumab, an anti-amyloid beta antibody developed for subcutaneous administration, as an Alzheimer’s disease treatment.
Antibiotic prescribing in pediatric practices declined 73% amid pandemic
Researchers observed a significant reduction in antibiotic prescriptions among pediatric primary care centers in Pennsylvania and New Jersey after the start of the COVID-19 pandemic.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read